“Developing New Medicines for Disease of Poverty”
Guest Speaker :
Victoria G. Hale, Ph. D.
Founder and Chief Executive Officer Institute for OneWorld Health
– A Non Profit Pharmaceutical Company
Directors, Institute for OneWorld Health . Dr. Hale established her expertise in all stages of biopharmaceutical drug development at the US Food and Drug Administration (FDA), Center for Drug Evaluation and Research; at Genentech, Inc., the world’s first biotechnology company; and as Co-founder and Chief Scientific Officer of Axiom BioMedical, Inc., a pharmaceutical development and liability consultancy. She presently maintains an Adjunct Associate Professorship in Biopharmaceutical Sciences at the University of California, San Francisco (UCSF), is an Advisor to the World Health Organization (WHO) for building ethical review capacity in the developing world, and has served as an expert reviewer to the National Institutes of Health (NIH) on the topic of biodiversity.
Dr. Hale and OneWorld Health were recently included in the Scientific American 50, the magazine’s annual list recognizing outstanding acts of leadership in science and technology from the past year (2004). She was also named one of 2004’s “Most Outstanding Social Entrepreneurs” by the Schwab Foundation for Social Entrepreneurship in Switzerland and selected as a Leadership Foundation Fellow of the International Women’s Forum in September 2003. Dr. Hale earned her Ph.D. in Pharmaceutical Chemistry from UCSF.
Date: Tuesday, July 12, 2005
Time: 6:30 PM
Place: Basque Cultural Center,599 Railroad Ave., South San Francisco, CA 94080 Ph: 650-583-8091.
Early registration: $ 15
On-site registration: $ 20
EPPIC / Affliate Members
Early registration: $ 30
On-site registration: $ 35
Early registration: $ 40
On-site registration: $ 45
This Event is Sponsored By
South Asians Network @ Genentech